Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing

[1] Single-nucleotide polymorphism analysis by pyrosequencing [J]. ANALYTICAL BIOCHEMISTRY, 2000, 280 (01) : 103 - 110

[2] Akaba K, 1998, BIOCHEM MOL BIOL INT, V46, P21

[3] IDENTIFICATION OF DEFECT IN THE GENES FOR BILIRUBIN UDP-GLUCURONOSYL-TRANSFERASE IN A PATIENT WITH CRIGLER-NAJJAR SYNDROME TYPE-II [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (03) : 1239 - 1244

[4] Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter:: A balanced polymorphism for regulation of bilirubin metabolism? [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 8170 - 8174

[5] Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus [J]. PHARMACOGENETICS, 2001, 11 (04): : 357 - 368

[6] Variations of the bilirubin uridine-diphosyphoglucuronosyl transferase 1A1 gene in healthy Taiwanese [J]. PHARMACOGENETICS, 2000, 10 (06): : 539 - 544

[7] Genetic predisposition to the metabolism of irinotecan (CPT-11) - Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) : 847 - 854

[8] Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D [J]. DRUG METABOLISM AND DISPOSITION, 2003, 31 (01) : 108 - 113

[9] Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome [J]. LANCET, 1996, 347 (9001) : 578 - 581

[10] Saeki Mayumi, 2002, Drug Metab Pharmacokinet, V17, P488, DOI 10.2133/dmpk.17.488

[1] Single-nucleotide polymorphism analysis by pyrosequencing [J]. ANALYTICAL BIOCHEMISTRY, 2000, 280 (01) : 103 - 110

[2] Akaba K, 1998, BIOCHEM MOL BIOL INT, V46, P21

[3] IDENTIFICATION OF DEFECT IN THE GENES FOR BILIRUBIN UDP-GLUCURONOSYL-TRANSFERASE IN A PATIENT WITH CRIGLER-NAJJAR SYNDROME TYPE-II [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (03) : 1239 - 1244

[4] Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter:: A balanced polymorphism for regulation of bilirubin metabolism? [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 8170 - 8174

[5] Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus [J]. PHARMACOGENETICS, 2001, 11 (04): : 357 - 368

[6] Variations of the bilirubin uridine-diphosyphoglucuronosyl transferase 1A1 gene in healthy Taiwanese [J]. PHARMACOGENETICS, 2000, 10 (06): : 539 - 544

[7] Genetic predisposition to the metabolism of irinotecan (CPT-11) - Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) : 847 - 854

[8] Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D [J]. DRUG METABOLISM AND DISPOSITION, 2003, 31 (01) : 108 - 113

[9] Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome [J]. LANCET, 1996, 347 (9001) : 578 - 581

[10] Saeki Mayumi, 2002, Drug Metab Pharmacokinet, V17, P488, DOI 10.2133/dmpk.17.488